NewsSource: EClinCloud

EClinCloud Product Overview | CTMS: Clinical Trial Management System

2 min readEClinCloud Editorial Team
Article figure

Source: EClinCloud. Author: EClinCloud.

Article figure



EClinCloud CTMS (Clinical Trial Management System) is a project-management-centered system spanning the entire clinical trial lifecycle. It is primarily used for project management, timeline management, subject management, quality management, and cost management across all phases of a clinical trial. Through the EClinCloud CTMS, investigators can track and monitor trial projects online in real time, effectively reducing clinical trial management costs and improving clinical trial management quality and efficiency.




CTMS

One-Stop Product + Service Solution



1

What EClinCloud Provides

1

CTMS System

2

System training and configuration services

3

Project management SOPs and business templates


2

Features of EClinCloud CTMS

1

Lightly customized CTMS services for rapid deployment of a tailored system adapted to management needs

2

Visual dashboards for real-time end-to-end tracking, enabling investigators to quickly review project status

3

Intelligent monitoring visit and protocol deviation reporting to reduce frontline and management workload

4

Bilingual (Chinese and English) business template configuration and full-time-zone audit trail



3

Why Choose EClinCloud CTMS?

Article figure

Enables standardized, systematic, and granular management across the entire clinical trial lifecycle

Comprehensive functional modules with a flexible, configurable system architecture

Backed by professional domestic and international service teams capable of promptly delivering specialized project experience and solutions to clients

EClinCloud CTMS integrates with EDC and eTMF systems to enable subject information sharing and synchronized document management






About EClinCloud

EClinCloud is a technology company dedicated to clinical R&D. It provides an integrated, interoperable cloud platform for clinical trials (including technology products and solutions such as eCOA, CTMS, eTMF, EDC, RTSM, and RM, as well as solutions within them including scale design, scale copyright management, linguistic validation, rater training, and data quality analysis) and clinical trial endpoint assessment technologies across therapeutic areas (such as central nervous system disorders and ophthalmology). Combining frontier technology with life sciences data, EClinCloud builds a globally leading "patient-centric" SaaS cloud platform supporting clinical evidence, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the launch of drugs and medical devices, and benefit countless patients.







Article figure

Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.